Biotech Values

[BiotechValues]

Microcap $BIAD zero debt, zero dilution, $1M + revenues (up from zero) & undiscovered

I received permission from DewDiligence to post about Bio-AMD (BIAD) here.

This stock is definitely not for everyone due to being pretty much unknown and thinly traded, but I believe BIAD will be commercializing their hand-held blood COAG measurement device next year with Sysmex Corp, a $ 9 billion biotech company with a strong presence in Europe and Asia.

If you have a high risk tolerance and a 6-12 month horizon, BIAD might be appropriate for you- but it is still a high risk investment.

The company bought the technology out of bankruptcy and I believe shareholders will reap the rewards when it's commercialized. Questcor comes to mind- although that's an extreme example I cite in the article.

More on BIAD in my article here: Why Bio-AMD (BIAD) Shares are Poised to Move Higher